Renal Insufficiency clinical trials at UCLA
1 research study open to eligible people
open to all eligible people
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Van Nuys, California and other locations
Our lead scientists for Renal Insufficiency research studies include Jessica Stewart.